Testing effectiveness (Phase 2)Study completedNCT00811369
What this trial is testing
Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer
Who this might be right for
Metastatic Breast Cancer
Ontario Clinical Oncology Group (OCOG) 126